ImmunityBio, Inc. Quarterly Depreciation in USD from Q1 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
ImmunityBio, Inc. quarterly/annual Depreciation history and growth rate from Q1 2016 to Q2 2024.
  • ImmunityBio, Inc. Depreciation for the quarter ending June 30, 2024 was $3.9M, a 7.14% decline year-over-year.
  • ImmunityBio, Inc. Depreciation for the twelve months ending June 30, 2024 was $16M, a 5.88% decline year-over-year.
  • ImmunityBio, Inc. annual Depreciation for 2023 was $16.5M, a 1.23% increase from 2022.
  • ImmunityBio, Inc. annual Depreciation for 2022 was $16.3M, a 14.8% increase from 2021.
  • ImmunityBio, Inc. annual Depreciation for 2021 was $14.2M, a 11.8% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $16M $3.9M -$300K -7.14% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $16.3M $4M -$200K -4.76% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $16.5M $4M -$500K -11.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $17M $4.1M $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $17M $4.2M +$300K +7.69% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $16.7M $4.2M +$400K +10.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $16.3M $4.5M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 $4.1M +$400K +10.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $3.9M -$100K -2.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $3.8M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $3.7M +$1.3M +54.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $4M +$1.7M +73.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q4 2020 $12.7M $5.8M +$3.6M +164% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $9.1M $2.4M +$200K +9.09% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $8.9M $2.3M +$100K +4.55% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $8.8M $2.2M +$400K +22.2% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $8.4M $2.2M $0 0% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 $8.4M $2.2M $0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $8.4M $2.2M +$400K +22.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $8M $1.8M +$700K +63.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $7.3M $2.2M +$1.2M +120% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-04
Q3 2018 $6.1M $2.2M +$1.3M +144% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $4.8M $1.8M +$1M +125% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $3.8M $1.1M +$500K +83.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $3.3M $1M +$437K +77.6% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-25
Q3 2017 $2.86M $900K +$600K +200% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $2.26M $800K +$700K +700% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $1.56M $600K +$563K +1522% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 $1M $563K Oct 1, 2016 Dec 31, 2016 10-K 2019-03-13
Q3 2016 $300K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $100K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $37K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.